-+ 0.00%
-+ 0.00%
-+ 0.00%

CLOUDBREAK PHARMA - FDA COMPLETES SAFETY REVIEW OF CBT-358 IND APPLICATION WITH NO OBJECTION

Reuters·07/17/2026 10:39:16

Please log in to view news